How a new investment is powering a revolution in clinical trial operations
pharmaphorum
DECEMBER 6, 2022
Iddo Peleg (CEO, and one of the four co-founders of YonaLink) and Gav Martell (co-founder and vice president of business development) discussed how a recent $6 million funding round led by Debiopharm Innovation Fund will support their mission to transform clinical trials and bring lifesaving therapies to market faster.
Let's personalize your content